Loading...

Potential use of COX-2–aromatase inhibitor combinations in breast cancer

Cyclooxygenase-2 (COX-2) is overexpressed in several epithelial tumours, including breast cancer. Cyclooxygenase-2-positive tumours tend to be larger, higher grade, node-positive and HER-2/neu-positive. High COX-2 expression is associated with poor prognosis. Cyclooxygenase-2 inhibition reduces the...

Full description

Saved in:
Bibliographic Details
Main Authors: Bundred, N J, Barnes, N L P
Format: Artigo
Language:Inglês
Published: Nature Publishing Group 2005
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361689/
https://ncbi.nlm.nih.gov/pubmed/16100520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602690
Tags: Add Tag
No Tags, Be the first to tag this record!